Ref ID: 19229
Author:
F. Cheikhrouhou, I. Hadrich, S. Neji, H. Trabelsi, H. Sellami, A. Znazen*, F. Makni, A. Ayadi
Author address:
Sfax, TN
Full conference title:
23rd European Congress of Clinical Microbiology and
Infectious Diseases
Date: 27 April 2014
Abstract:
Invasive aspergillosis (IA) is a major cause of morbidity and mortality in profoundly neutropenic patients. Delayed diagnosis and therapy may lead to poor outcomes.
Aims: The objective of this study was to assess the performance characteristics of the galactomannan (GM) assay in serum and broncho-alveolar lavage specimen for the diagnosis of IA in neutropenic patients with heamatological malignancies. We also evaluated the prognosis outcome.
Patients and Methods: A total of 1198 serum samples and 42 BAL from 235 neutropenic patients were tested with a GM ELISA platelia test. We used Cox modeling of time to 6 and 12-week mortality for the GM level at the time of diagnosis (GM0) and GM decay in the week following diagnosis in proven and probable IA patients with >2 GM values.
Results: There were 3 proven, 55 probable, and 4 possible cases of IA. The sensitivity and the specificity of GM test were 96.8% and 82.4% respectively. In BAL samples, sensitivity was 86% and the specificity was 93%. BAL GM was more sensitive than microscopy (22.2%) and BAL culture (38.9%). Among the patients with proven/probable IA, serum and BAL GM were in agreement for 92.8% of paired samples. The hazard ratio (HR) of GM0 and 1-week GM decay per unit increase in EIA was 1.044 (95% CI, 0.738 to 1.476) and 0.709 (95% CI, 0.236 to 2.130) respectively.
Conclusion: We conclude to good correlation between GM0 and GM decay combination and outcome of IA patients. The GM is a useful tool for the diagnosis and monitoring of the course of IA.
Abstract Number: P1735
Conference Year: 2013
Link to conference website: http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=164479&XNSPRACHE_ID=2&XNKONGRESS_ID=180&XNMASK
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a